Preparing for Myeloma CAR-T Cell Therapy | What to Expect
https://vimeo.com/1164531947 Dr. Ciara Freeman provides an overview of what patients and care partners can expect before CAR T-cell therapy—from deciding if CAR T is right for you to getting physically…
How Has Myeloma CAR T-Cell Therapy Changed in Recent Years?
https://vimeo.com/1164531973 Dr. Ciara Freeman, a myeloma specialist from Moffitt Cancer Center, explains CAR T-cell therapy in simple terms, sharing how this treatment is changing the future for people with myeloma….
Research Updates From ASH | Myeloma CAR T-Cell Therapy
https://vimeo.com/1164531982 Myeloma expert and researcher Dr. Ciara Freeman shares key CAR T-cell therapy advances presented at the 2025 American Society of Hematology (ASH) meeting. Dr. Freeman also provides an explanation…
[ACT]IVATED CAR T-Cell Therapy Toolkit Checklist III
Download Checklist Download Checklist See More from [ACT]IVATED CAR T-Cell Therapy
[ACT]IVATED CAR T-Cell Therapy Resource Guide IV
Download Resource Guide Download Resource Guide See More from [ACT]IVATED CAR T-Cell Therapy
复发后的骨髓瘤：新研究对患者的意义
https://vimeo.com/1160266766 德克萨斯大学MD安德森癌症中心的Krina K. Patel医学博士讨论了MAJESTIC-3临床试验中令人鼓舞的新数据，该研究针对首次复发后的多发性骨髓瘤患者，评估了两种免疫疗法联合使用的效果。她解释了这种治疗方法的工作原理、为何研究结果如此令人振奋，以及为何支持性治疗对于安全管理治疗至关重要。Patel医生还分享了实用见解，帮助患者理解这一治疗选择在其整体治疗路径中的潜在定位，在带来希望的同时，强调经过深思熟虑的个体化决策的重要性。 See More from [ACT]IVATED Multiple Myeloma Related Resources What Are Myeloma Risk Factors for Veterans and First Responders? How AI Is Shaping the Future of CAR…
Mieloma Después de la Recaída: Lo Que la Nueva Investigación Significa para los Pacientes
https://vimeo.com/1160265495 La Dra. Krina K. Patel del Centro de Cáncer MD Anderson de la Universidad de Texas analiza datos alentadores del ensayo clínico MAJESTIC-3, que estudió una combinación de dos…
Myeloma After Relapse: What New Research Means for Patients
https://vimeo.com/1160264387 Dr. Krina K. Patel of The University of MD Anderson Cancer Center discusses encouraging new data from the MAJESTIC-3 clinical trial, which studied a combination of two immunotherapies for…
ELEVATE | From Research to Recovery: CAR T-Cell Therapy for Myeloma Patients
https://vimeo.com/1159341084 Dr. Ciara Freeman, a myeloma specialist at Moffitt Cancer Center, discusses recent advances in myeloma CAR T-cell therapy from the 2025 American Society of Hematology (ASH) annual meeting and…
How AI Is Shaping the Future of CAR T and Myeloma Care
https://vimeo.com/1158519733 Exploring the intersection of artificial intelligence and next-generation cancer therapies, Lisa Hatfield, who brings the perspective of living with multiple myeloma, speaks with Dr. Krina K. Patel of The…
Staying [ACT]IVATED Ahead of Relapse: Improving CAR T Durability in Myeloma
https://vimeo.com/1158519769 In a forward-looking discussion on the future of CAR T-cell therapy, Lisa Hatfield, who brings the perspective of living with multiple myeloma, speaks with Dr. Krina K. Patel of…
Getting to CAR T: How Patients Can Overcome Access Barriers
https://vimeo.com/1158519876 Exploring the real-world barriers that can delay access to CAR T-cell therapy, Lisa Hatfield, speaks with Dr. Krina K. Patel of The University of Texas MD Anderson Cancer Center…